Gastrointestinal Cancers Symposium

The latest news from ASCO GI, including researcher interviews and physician perspective.


Meeting News CoveragePerspective

Some patients with rectal cancer may safely avoid surgery

January 12, 2015
A watch-and-wait surveillance strategy conferred similar 4-year survival rates as immediate surgery among patients with stage I to stage III rectal…
Meeting News CoveragePerspective

RAS status determined panitumumab benefit in colorectal cancer

January 21, 2014
Additional RAS testing beyond exon 2 may be necessary to identify patients with metastatic colorectal cancer who are unlikely to benefit from…
Meeting News CoveragePerspective

Oral capecitabine may be new standard of care in rectal cancer

January 16, 2014
Oral capecitabine plus radiation therapy appeared as effective and well tolerated as 5-FU plus radiation therapy and may be considered the new…
Meeting News CoveragePerspective

Chemotherapy combination shows promise as second-line therapy for neuroendocrine tumors

January 15, 2014
The combination of capecitabine plus temozolomide demonstrated efficacy in patients with well- to moderately differentiated neuroendocrine tumors…
Meeting News CoveragePerspective

Vaccine combination extended survival in metastatic pancreatic cancer

January 14, 2014
Combination treatment with the GVAX pancreatic cancer vaccine and CRS-207 vaccine extended survival with manageable toxicity compared with the GVAX…
Meeting News CoveragePerspective

Ramucirumab plus paclitaxel improved OS, PFS in advanced gastric cancer

January 14, 2014
Patients with advanced gastric adenocarcinoma treated with ramucirumab plus paclitaxel demonstrated improved OS, PFS and quality of life compared…

Advances in gastroesophageal adenocarcinoma, pancreatic cancer highlight GI symposium

HemOnc Today, March 25, 2013
David H. Ilson, MD, PhD
The 2013 Gastrointestinal Cancers Symposium, the 10th annual international meeting organized by gastroenterologists, surgeons, and medical and…
Meeting News CoveragePerspectivePublication Exclusive

Combination therapy extends survival among patients with advanced pancreatic cancer

HemOnc Today, February 25, 2013
The addition of nab-paclitaxel to gemcitabine significantly improved survival in treatment-naïve patients with metastatic pancreatic cancer…
Perspective

Ramucirumab increased survival among patients with advanced gastric cancer

HemOnc Today, February 25, 2013
The novel drug ramucirumab significantly improved survival compared with placebo among patients with metastatic refractory gastric or…
Meeting News CoveragePerspectivePublication Exclusive

Gene expression profiling may help guide pancreatic cancer treatment

HemOnc Today, February 25, 2013
Pharmacogenomic profiling of circulating tumor cells in the bloodstream may help personalize the choice of chemotherapy for patients with pancreatic…